Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7

Authors: G. M. Humphris, E. Watson, M. Sharpe, G. Ozakinci

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

The assessment of fear of recurrence (FCR) is crucial for understanding an important psychological state in patients diagnosed and treated for cancer. The study aim was to determine psychometric details of a seven question self-report scale (FCR7) and a short form (FCR4) based upon items already used in various extensive measures of FCR.

Methods

Two consecutive samples of patients (breast and colorectal) were recruited from a single specialist cancer centre. The survey instrument contained the FCR7 items, Hospital Anxiety and Depression Scale (HADS), and demographic details. Clinical information was obtained from patient hospital records. Statistical analyses were performed using classical test and item response theory approaches, to demonstrate unidimensional factor structure and testing key parameters. Construct validity was inspected through nomological and theoretical prediction.

Results

Internal consistency was demonstrated by alpha coefficients (FCR4: 0.93 and FCR7: 0.92). Both scales (FCR7 & FCR4) were associated with the HADs subscales as predicted. Patients who experienced chemotherapy, minor aches/pains, thought avoidance of cancer and high cancer risk belief were more fearful. Detailed inspection of item responses profile provided some support for measurement properties of scales.

Conclusion

The internal consistency, and pattern of key associations and discriminability indices provided positive psychometric evidence for these scales. The brief measures of FCR may be considered for audit, screening or routine use in clinical service and research investigations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300–22. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S, et al. Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv. 2013;7:300–22.
2.
go back to reference Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21:571–87.CrossRefPubMed Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psychooncology. 2012;21:571–87.CrossRefPubMed
3.
go back to reference Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology. 2017;26:1444-54. Simonelli LE, Siegel SD, Duffy NM. Fear of cancer recurrence: a theoretical review and its relevance for clinical presentation and management. Psychooncology. 2017;26:1444-54.
4.
go back to reference Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract. 2007;57:144–51.PubMedPubMedCentral Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract. 2007;57:144–51.PubMedPubMedCentral
5.
go back to reference Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, et al. Empirical validation of the English version of the fear of cancer recurrence inventory. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2016;25:311–21. Lebel S, Simard S, Harris C, Feldstain A, Beattie S, McCallum M, et al. Empirical validation of the English version of the fear of cancer recurrence inventory. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2016;25:311–21.
6.
go back to reference Costa DS, Smith AB, Fardell JE. The sum of all fears: conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer. 2016;24:1–3.CrossRefPubMed Costa DS, Smith AB, Fardell JE. The sum of all fears: conceptual challenges with measuring fear of cancer recurrence. Support Care Cancer. 2016;24:1–3.CrossRefPubMed
7.
go back to reference Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68–79.CrossRefPubMed Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The concerns about recurrence questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68–79.CrossRefPubMed
8.
go back to reference Ness AR, Waylen A, Hurley K, Jeffreys M, Penfold C, Pring M, et al. Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000. Clin Otolaryngol. 2016;41:804–9.CrossRefPubMedPubMedCentral Ness AR, Waylen A, Hurley K, Jeffreys M, Penfold C, Pring M, et al. Recruitment, response rates and characteristics of 5511 people enrolled in a prospective clinical cohort study: head and neck 5000. Clin Otolaryngol. 2016;41:804–9.CrossRefPubMedPubMedCentral
9.
go back to reference Rogers SN, Cross B, Talwar C, Lowe D, Humphris G. A single-item screening question for fear of recurrence in head and neck cancer. Eur Arch Otorhinolaryngol. 2016;273:1235–42.CrossRefPubMed Rogers SN, Cross B, Talwar C, Lowe D, Humphris G. A single-item screening question for fear of recurrence in head and neck cancer. Eur Arch Otorhinolaryngol. 2016;273:1235–42.CrossRefPubMed
10.
go back to reference Ness AR, Waylen A, Hurley K, Jeffreys M, Penfold C, Pring M, et al. Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000. BMC Cancer. 2014;14:973.CrossRefPubMedPubMedCentral Ness AR, Waylen A, Hurley K, Jeffreys M, Penfold C, Pring M, et al. Establishing a large prospective clinical cohort in people with head and neck cancer as a biomedical resource: head and neck 5000. BMC Cancer. 2014;14:973.CrossRefPubMedPubMedCentral
11.
go back to reference Streiner DL, Norman GR. Health measurement scales - a practical guide to their development and use. Oxford: Oxford University Press; 1992. Streiner DL, Norman GR. Health measurement scales - a practical guide to their development and use. Oxford: Oxford University Press; 1992.
12.
go back to reference Clark L, Watson D. Construct validity: basic issues in objective scale development. Psychol Assess. 1995;7:309–19.CrossRef Clark L, Watson D. Construct validity: basic issues in objective scale development. Psychol Assess. 1995;7:309–19.CrossRef
13.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.CrossRefPubMed
14.
go back to reference Fong TC, Ho RT. Testing gender invariance of the hospital anxiety and depression scale using the classical approach and Bayesian approach. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2014;23:1421–6. Fong TC, Ho RT. Testing gender invariance of the hospital anxiety and depression scale using the classical approach and Bayesian approach. Qual Life Res Int J Qual Life Asp Treat Care Rehab. 2014;23:1421–6.
15.
go back to reference Lee-Jones C, Humphris G, Dixon R, Bebbington-Hatcher M. Fear of cancer recurrence: a literature review and formulation to explain exacerbation of recurrence fears. Psycho-Oncology. 1997;6:95–105.CrossRefPubMed Lee-Jones C, Humphris G, Dixon R, Bebbington-Hatcher M. Fear of cancer recurrence: a literature review and formulation to explain exacerbation of recurrence fears. Psycho-Oncology. 1997;6:95–105.CrossRefPubMed
16.
go back to reference Nelson DV, Friedman LC, Baer PE, Lane M, Smith FE. Attitudes to cancer: psychometric properties of fighting Spirit and denial. J Behav Med. 1989;12:341–55.CrossRefPubMed Nelson DV, Friedman LC, Baer PE, Lane M, Smith FE. Attitudes to cancer: psychometric properties of fighting Spirit and denial. J Behav Med. 1989;12:341–55.CrossRefPubMed
18.
go back to reference Yang Y, Cameron J, Humphris G. The relationship between cancer patient’s fear of recurrence and radiotherapy: a systematic review and meta-analysis. Psychooncology. 2017;26:738-46. Yang Y, Cameron J, Humphris G. The relationship between cancer patient’s fear of recurrence and radiotherapy: a systematic review and meta-analysis. Psychooncology. 2017;26:738-46.
19.
go back to reference Yang Y, Yunhong W, Bedi C, Humphris G. The Relationship between Cancer Patient’s Fear of Recurrence and Chemotherapy: A Systematic Review and Meta-Analysis. J Psychosom Res. 2017;98:55-63. Yang Y, Yunhong W, Bedi C, Humphris G. The Relationship between Cancer Patient’s Fear of Recurrence and Chemotherapy: A Systematic Review and Meta-Analysis. J Psychosom Res. 2017;98:55-63.
20.
go back to reference Lorenzo-Seva U, Ferrando P. FACTOR: a computer program to fit the exploratory factor analysis model. Behav Res Methods Instrum Comput. 2006;38:88–91.CrossRef Lorenzo-Seva U, Ferrando P. FACTOR: a computer program to fit the exploratory factor analysis model. Behav Res Methods Instrum Comput. 2006;38:88–91.CrossRef
21.
go back to reference Thompson B. Exploratory and confirmatory factor analysis: understanding concepts and applications. Washington, DC: American Psychological Association; 2004.CrossRef Thompson B. Exploratory and confirmatory factor analysis: understanding concepts and applications. Washington, DC: American Psychological Association; 2004.CrossRef
22.
go back to reference Horn J. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–85.CrossRefPubMed Horn J. A rationale and test for the number of factors in factor analysis. Psychometrika. 1965;30:179–85.CrossRefPubMed
24.
go back to reference Brown T. Confirmatory factor analysis for applied research. New York: Guilford Press; 2006. Brown T. Confirmatory factor analysis for applied research. New York: Guilford Press; 2006.
25.
go back to reference Baker F. The basics of item response theory. 2nd ed; 2001. Baker F. The basics of item response theory. 2nd ed; 2001.
26.
go back to reference Tay L, Meade AW, Cao M. An overview and practical guide to IRT measurement equivalence analysis. Organ Res Methods. 2015;18:3–46.CrossRef Tay L, Meade AW, Cao M. An overview and practical guide to IRT measurement equivalence analysis. Organ Res Methods. 2015;18:3–46.CrossRef
27.
go back to reference Allen MJ, Yen W. Introduction to measurement theory. Long Grove: Waveland Press; 2002. Allen MJ, Yen W. Introduction to measurement theory. Long Grove: Waveland Press; 2002.
28.
go back to reference van Helmondt SJ, van der Lee ML, de Vries J. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer. BMC Cancer. 2016;16:527.CrossRefPubMedPubMedCentral van Helmondt SJ, van der Lee ML, de Vries J. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer. BMC Cancer. 2016;16:527.CrossRefPubMedPubMedCentral
29.
go back to reference Simard S, Savard J, Gonthier C, Tremblay V, Maheux J. Development and empirical validation of the fear of cancer recurrence inventory. Psycho-Oncology. 2005;14:S51-S. Simard S, Savard J, Gonthier C, Tremblay V, Maheux J. Development and empirical validation of the fear of cancer recurrence inventory. Psycho-Oncology. 2005;14:S51-S.
30.
go back to reference Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9:481–91.CrossRefPubMed Simard S, Savard J. Screening and comorbidity of clinical levels of fear of cancer recurrence. J Cancer Surviv. 2015;9:481–91.CrossRefPubMed
31.
go back to reference Leventhal H, Nerenz D, Steele D. Illness representations and coping with health threats. In: Baum A, Taylor S, Singer J, editors. Handbook of psychology and health, volume IV: social psychological aspects of health. Hillsdale: Erlbaum; 1984. p. 219–52. Leventhal H, Nerenz D, Steele D. Illness representations and coping with health threats. In: Baum A, Taylor S, Singer J, editors. Handbook of psychology and health, volume IV: social psychological aspects of health. Hillsdale: Erlbaum; 1984. p. 219–52.
32.
go back to reference Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value Health. 2009;12:419–29.CrossRefPubMed Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, et al. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report. Value Health. 2009;12:419–29.CrossRefPubMed
33.
go back to reference Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24:3265–8.CrossRefPubMed Lebel S, Ozakinci G, Humphris G, Mutsaers B, Thewes B, Prins J, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24:3265–8.CrossRefPubMed
34.
go back to reference Costa DS. Screening for clinical levels of fear of cancer recurrence. Psychooncology. 2017;26:2002-3. Costa DS. Screening for clinical levels of fear of cancer recurrence. Psychooncology. 2017;26:2002-3.
35.
go back to reference Cruickshank S, Steel E, Fenlon D, Armes J, Scanlon K, Banks E, et al. A feasibility study of the mini-AFTER telephone intervention for the management of fear of recurrence in breast cancer survivors: a mixed-methods study protocol. Pilot Feasibility Stud. 2018;4:22.CrossRefPubMed Cruickshank S, Steel E, Fenlon D, Armes J, Scanlon K, Banks E, et al. A feasibility study of the mini-AFTER telephone intervention for the management of fear of recurrence in breast cancer survivors: a mixed-methods study protocol. Pilot Feasibility Stud. 2018;4:22.CrossRefPubMed
36.
go back to reference van Helmondt SJ, van der Lee ML, de Vries J. Translation and validation of the Dutch version of the fear of cancer recurrence inventory (FCRI-NL). J Psychosom Res. 2017;102:21–8.CrossRefPubMed van Helmondt SJ, van der Lee ML, de Vries J. Translation and validation of the Dutch version of the fear of cancer recurrence inventory (FCRI-NL). J Psychosom Res. 2017;102:21–8.CrossRefPubMed
37.
go back to reference Shin J, Goo A, Ko H, Kim JH, Lim SU, Lee HK, et al. Validation study for the Korean version of fear of cancer recurrence inventory. J Korean Med Sci. 2017;32:1792–9.CrossRefPubMedPubMedCentral Shin J, Goo A, Ko H, Kim JH, Lim SU, Lee HK, et al. Validation study for the Korean version of fear of cancer recurrence inventory. J Korean Med Sci. 2017;32:1792–9.CrossRefPubMedPubMedCentral
38.
go back to reference Adler M, Hetta J, Isacsson G, Brodin U. An item response theory evaluation of three depression assessment instruments in a clinical sample. BMC Med Res Methodol. 2012;12:84.CrossRefPubMedPubMedCentral Adler M, Hetta J, Isacsson G, Brodin U. An item response theory evaluation of three depression assessment instruments in a clinical sample. BMC Med Res Methodol. 2012;12:84.CrossRefPubMedPubMedCentral
39.
go back to reference Costa DS, Dieng M, Cust AE, Butow PN, Kasparian NA. Psychometric properties of the fear of cancer recurrence inventory: an item response theory approach. Psychooncology. 2016;25:832–8.CrossRefPubMed Costa DS, Dieng M, Cust AE, Butow PN, Kasparian NA. Psychometric properties of the fear of cancer recurrence inventory: an item response theory approach. Psychooncology. 2016;25:832–8.CrossRefPubMed
Metadata
Title
Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7
Authors
G. M. Humphris
E. Watson
M. Sharpe
G. Ozakinci
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-0850-x

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue